TABLE 3: Outbreaks of Acinetobacter baumannii in Brazil.

Study	Place of study	Year of outbreak	Place of outbreak	No. of patients	Antibiotic Resistance	Reported genes
DALIA-COSTA et al., 2003	Curitiba	1999	Ward	8	IPM, MEM, CIP, and AMG	bla OXA-23
BRITO et al., 2005	Uberlândia	2005	NICU	11	GEN, CIP, CAZ, FEP, and ATM	-
TAKAGI et al., 2009	São Paulo	2005-2006	ICU	8	PIP, TZP, CAZ, CTX, ATM, IPM, MEM, CIP, AMK, GEN, and SXT	bla OXA-51
MARTINS et al., 2009	Porto Alegre	2007	DHW	53	CIP, GEN, TZP, and SXT	bla OXA-51, bla OXA-23
GUSATTI et al., 2012	Porto Alegre	2007	Ward	74	IPM, MEM, AMK, CIP, GEN, CET, AMA, SXT, and TIM	bla OXA-51, bla OXA-58, bla OXA-65, ISAba1/OXA-51
PAGANO et al., 2015	Porto Alegre	2011	DHW	122	FEP, CIP, CAZ, AMA, AMK, PMB, IMP and MEM	bla OXA-23
CASTILHO et al., 2017	Goiás	2010	ICU	64	AMA, FEP, AMK, PMB, and TGC	ISAba1/OXA-23 and ISAba1/OXA-51, bla OXA-51, bla OXA-23, bla OXA-58
MACIEL et al., 2017	Dourados	2013-2015	NICU	21	AMA, TZP, CAZ, CRO, FEP, GEN, AMK, CIP, and TGC.	ISAba1/OXA-23 and ISAba1/OXA-51

ICU: intensive care unit; NICU: neonatal intensive care unit; DHW: different hospital wards; IPM: imipenem; MEM: meropenem; CIP: ciprofloxacin; AMG: aminoglycoside; GEN: gentamicin; CAZ: ceftazidime; FEP: cefepime; ATM: aztreonam; TZP: piperacillin/tazobactam; AMK: amikacin; SXT: trimethoprim/sulfamethoxazole; CET: cephalothin; TIM: ticarcillin/clavulanic acid; PMB: polymyxin B; TGC: tigecycline; CRO: ceftriaxone; AMA: ampicillin/sulbactam; CTX: cefotaxime; PIP: piperacillin.